Jakarta, InfoPublik – The risk of death from cervical cancer is high, Health Minister (Menkes) Budi Gunadi Sadikin stressed that cervical cancer can be prevented, one of which is by giving immunization against human papillomavirus (HPV), especially to children.
The administration of the HPV vaccine is supported by the issuance of the decree of the Minister of Health of the Republic of Indonesia number HK.01.07/MENKES/6779/2021 regarding the human papillomavirus vaccine introduction program for 2022-2024.
“We can eliminate the cancer virus by increasing HPV immunization coverage in every city so that we can reduce mortality and costs due to cancer,” Health Minister Budi said on Tuesday (12/13/2022).
For this to happen, Health Minister Budi said that the availability of the HPV vaccine is one of the important aspects that need to be prepared. For this reason, the Ministry of Health and BUMN BUMN Holding are stepping up efforts to develop and produce home HPV vaccines by collaborating with PT Marck (MSD).
On this occasion, Health Minister Budi appreciated and welcomed the collaboration between the two, which was seen as a demonstration of their intention to work together to improve efforts to fight cervical cancer in Indonesia.
“I believe that with the potential for technology transfer, both MSD’s expertise, knowledge and experience as the world’s leading HPV vaccine manufacturer will be beneficial to Bio Farma and the independence of the healthcare sector in Indonesia, particularly in the development of vaccines,” continued Health Minister Budi.
Bio Farma director Honesti Basyir said that this collaboration was very good for Biofarma to strengthen the healthcare infrastructure by showcasing Indonesian quality and manufacturing of HPV vaccine. So that public access to the HPV vaccine is easier and faster.
“Cooperation is milestone for Biopharma. We would like to thank the Ministry of Health, the Ministry of BUMN and MSD for supporting us in providing a quality HPV vaccine,” said Honesti.
Cervical cancer is the second highest cause of death and one of the biggest financial burdens on healthcare in Indonesia.
Based on Globocan data for 2021, there are 36,633 cases of cervical cancer in Indonesia with the death rate rising. The causes vary from heredity, environment and unhealthy lifestyle, and viruses.
You can retransmit, rewrite and/or copy this content citing the source InfoPublik.id